IL1B and atherosclerosis: There are distinct regulatory mechanisms controlling proinflammatory cytokines IL-18 and IL-1β [Reviewed in (50)]; IL-18 is additionally activated via interferon signaling, which is abundant in atherosclerosis (51–53) and is prominent as a cluster in the RNA sequencing data (Figure 1F).